BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36613684)

  • 1. CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders.
    Kurishev AO; Karpov DS; Nadolinskaia NI; Goncharenko AV; Golimbet VE
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials and promising preclinical applications of CRISPR/Cas gene editing.
    Çerçi B; Uzay IA; Kara MK; Dinçer P
    Life Sci; 2023 Jan; 312():121204. PubMed ID: 36403643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
    Zhang Y; Karakikes I
    Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/dCas9 as a Therapeutic Approach for Neurodevelopmental Disorders: Innovations and Limitations Compared to Traditional Strategies.
    Ricci R; Colasante G
    Dev Neurosci; 2021; 43(3-4):253-261. PubMed ID: 33940579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas-Based Epigenome Editing: Advances, Applications, and Clinical Utility.
    Goell JH; Hilton IB
    Trends Biotechnol; 2021 Jul; 39(7):678-691. PubMed ID: 33972106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational designs of in vivo CRISPR-Cas delivery systems.
    Xu CF; Chen GJ; Luo YL; Zhang Y; Zhao G; Lu ZD; Czarna A; Gu Z; Wang J
    Adv Drug Deliv Rev; 2021 Jan; 168():3-29. PubMed ID: 31759123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of CRISPR-Cas systems in neuroscience.
    Bonnerjee D; Bagh S
    Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting CRISPR/Cas-mediated crop improvement: Special focus on nutrition.
    Kaul T; Sony SK; Verma R; Motelb KFA; Prakash AT; Eswaran M; Bharti J; Nehra M; Kaul R
    J Biosci; 2020; 45():. PubMed ID: 33361628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing
    Dehshahri A; Biagioni A; Bayat H; Lee EHC; Hashemabadi M; Fekri HS; Zarrabi A; Mohammadinejad R; Kumar AP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X; Shi W; Geng LZ; Xu JP
    Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the CRISPR-Cas system in cancer drug development: Mechanisms of action and therapy.
    Chandrasekaran AP; Karapurkar JK; Chung HY; Ramakrishna S
    Biotechnol J; 2022 Jul; 17(7):e2100468. PubMed ID: 35157790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research.
    Pandey PK; Quilichini TD; Vaid N; Gao P; Xiang D; Datla R
    Semin Cell Dev Biol; 2019 Dec; 96():107-114. PubMed ID: 31022459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRISPR-Cas toolbox and gene editing technologies.
    Liu G; Lin Q; Jin S; Gao C
    Mol Cell; 2022 Jan; 82(2):333-347. PubMed ID: 34968414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing for plant research and crop improvement.
    Zhan X; Lu Y; Zhu JK; Botella JR
    J Integr Plant Biol; 2021 Jan; 63(1):3-33. PubMed ID: 33369120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.